IRVINE, Calif. – May 3, 2017– AIVITA Biomedical today announced the appointment of operations executive Ed Inal as Chief Operating Officer. In this role Inal will oversee the day-to-day operations of AIVITA’s therapeutic pipeline and commercial line of skin care products. He brings with him extensive experience in both the medical and cosmetics spaces, having previously performed similar roles for notable beauty, wellness and medical device companies.

Prior to joining AIVITA Ed was Vice President of Operations and Customer Care at ALPHAEON Corporation, a lifestyle healthcare company committed to partnering with board-certified physicians to bring to market and develop highly innovative technologies and services that promote patient wellness, beauty and performance. There he was responsible for the launch of various commercialization efforts including establishing the supply chain, distribution, logistics, customer care and the ERP systems. He also previously served as Vice President of Customer Service and Support at Nobel Biocare.

“Ed’s experience with operations and commercialization are very impressive, and make him a perfect fit for AIVITA as we expand our clinical pipeline and commercial skin care efforts,” said Dr. Hans S. Keirstead, CEO of AIVITA.

About AIVITA Biomedical

AIVITA Biomedical is a privately held company engaged in the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. Founded in 2016 by pioneers in the stem cell industry, AIVITA Biomedical utilizes its expertise in stem cell growth and directed, high-purity differentiation to enable safe, efficient and economical manufacturing systems which support its commercial line of skin care products and therapeutic pipeline. All proceeds from the sale of PROVOQUE® directly support AIVITA’s Phase II clinical trial for the treatment of ovarian cancer.

###